Walther W, Stein U
Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany.
J Cancer Res Clin Oncol. 1994;120(8):471-8. doi: 10.1007/BF01191800.
We investigated the effects of tumor necrosis factor (TNF) alpha, interferon (IFN) gamma and interleukin-2 (IL-2) on the mdr1 gene expression in four human colon carcinoma cell lines (Lo Vo, HT 115, SW 480, and LS 174T) at different times (8, 24, 48, and 72 h). We found no significant changes in mdr1 expression after 8 h and 24 h of cytokine treatment in all four lines. After 48 h and 72 h, however, a marked reduction of mdr1 expression in Lo Vo, HT 115, and SW 480 cells and an unaffected expression in LS 174T cells was observed. We examined whether the cytokine-mediated reduction of mdr1 expression correlates to the multidrug resistance (MDR) phenotype. In those cell lines showing a decreased mdr1 expression after a long-term cytokine pretreatment we found a dramatic enhancement of cytotoxicity of the MDR relevant drugs vincristine and doxorubicin, whereas LS 174T cells remained resistant. By contrast, the simultaneous application of cytokines and cytostatics caused no additive or synergistic effects. We conclude that in certain colon carcinoma cell lines a decreased mdr1 expression caused by prolonged cytokine pretreatment correlates with an enhanced cytotoxicity of drugs susceptible to MDR as an MDR-overcoming effect.
我们研究了肿瘤坏死因子(TNF)α、干扰素(IFN)γ和白细胞介素-2(IL-2)在不同时间点(8、24、48和72小时)对四种人结肠癌细胞系(Lo Vo、HT 115、SW 480和LS 174T)中mdr1基因表达的影响。我们发现,在所有四种细胞系中,细胞因子处理8小时和24小时后,mdr1表达没有显著变化。然而,在48小时和72小时后,观察到Lo Vo、HT 115和SW 480细胞中mdr1表达明显降低,而LS 174T细胞中的表达未受影响。我们研究了细胞因子介导的mdr1表达降低是否与多药耐药(MDR)表型相关。在那些经过长期细胞因子预处理后mdr1表达降低的细胞系中,我们发现与MDR相关的药物长春新碱和阿霉素的细胞毒性显著增强,而LS 174T细胞仍然耐药。相比之下,细胞因子和细胞抑制剂的同时应用没有产生相加或协同作用。我们得出结论,在某些结肠癌细胞系中,长期细胞因子预处理导致的mdr1表达降低与对MDR敏感的药物增强的细胞毒性相关,这是一种克服MDR的效应。